,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1189,1,5,,48413394,10133,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
1,1199,1,3,,48413394,10133,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
2,1332,1,1,,49699071,10133,Inactive,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
3,1850,2,1,,56463362,10133,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
4,1863,2,1,,56463362,10133,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
5,1899,1,3,,56463362,10133,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
6,1903,2,3,,56463362,10133,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
7,1906,1,3,,56463362,10133,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
8,1947,1,2,,56463362,10133,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
9,1950,1,3,,56463362,10133,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
10,1962,1,2,,56463362,10133,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
11,1974,1,2,,56463362,10133,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
12,1987,1,2,,56463362,10133,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
13,2016,1,3,,56463362,10133,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
14,2023,1,3,,56463362,10133,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
15,2025,1,3,,56463362,10133,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
16,2029,1,3,,56463362,10133,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
17,2052,2,1,,56463362,10133,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
18,2057,1,2,,56463362,10133,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
19,2066,1,4,,56463362,10133,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
20,2101,1,1,,56463362,10133,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
21,2129,1,2,,56463362,10133,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
22,2130,1,3,,56463362,10133,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
23,2174,1,3,,56463362,10133,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
24,2177,1,3,,56463362,10133,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
25,2234,1,2,,56463362,10133,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
26,2235,1,2,,56463362,10133,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
27,2280,2,3,,56463362,10133,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
28,2300,1,3,,56463362,10133,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
29,2380,1,2,,56463362,10133,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
30,2391,1,1,,56463362,10133,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
31,2435,1,2,,56463362,10133,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
32,2445,1,2,,56463362,10133,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
33,2462,1,1,,56463362,10133,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
34,2462,1,1,,56463362,10133,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
35,2517,2,1,,56463362,10133,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
36,2517,2,1,,144203963,10133,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
37,2520,1,4,,56463362,10133,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
38,2521,1,3,,56463362,10133,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
39,2524,1,2,,56463362,10133,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
40,2540,1,2,,56463362,10133,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
41,2544,1,2,,56463362,10133,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
42,2557,1,3,,56463362,10133,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
43,2599,1,2,,56463362,10133,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
44,2606,1,2,,56463362,10133,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
45,2629,1,1,,56463362,10133,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
46,2650,2,1,,56463362,10133,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
47,2661,1,1,,56463362,10133,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
48,2676,1,2,,56463362,10133,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
49,2685,1,1,,56463362,10133,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
50,2690,1,2,,56463362,10133,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
51,2716,1,1,,56463362,10133,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
52,2717,1,2,,56463362,10133,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
53,2718,1,1,,56463362,10133,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
54,2751,2,2,,56463362,10133,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
55,2796,1,4,,56463362,10133,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
56,2797,1,2,,56463362,10133,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
57,2805,2,2,,56463362,10133,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
58,2806,2,2,,56463362,10133,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
59,2825,1,2,,56463362,10133,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
60,54340,3,3,,103542516,10133,Unspecified,,,,,Binding constant towards cyclodextrin conjugated peptide (with pyrene) at 25 degrees Centigrade,Other,14643314.0,
61,54341,3,3,,103542516,10133,Unspecified,,,,,Sensitivity value towards cyclodextrin conjugated peptide (with pyrene) at 25 degrees Centigrade,Other,14643314.0,
62,72525,10,5,,103542516,10133,Active,46577705.0,9971.0,8.66,EC50,Binding affinity for Farnesoid X Receptor (FXR),Confirmatory,12749886.0,
63,72526,10,5,,103542516,10133,Active,46577705.0,9971.0,8.66,EC50,Effective concentration against Farnesoid X receptor (FXR),Confirmatory,12166927.0,
64,72527,3,10,,103542516,10133,Unspecified,46577705.0,9971.0,,,Relative recruitment of SRC1 peptide to Farnesoid X receptor (FXR) where CDCA=100%,Other,12166927.0,
65,72530,3,10,,103542516,10133,Unspecified,46577705.0,9971.0,,,Farnesoid X-activated receptor activity compared to 50 uM chenodeoxycholic acid (CDCA),Other,10956205.0,
66,72531,8,5,,103542516,10133,Active,46577705.0,9971.0,3.4,EC50,Ligand dependent recruitment of SRC1(676-700) peptide to human Farnesoid X-activated receptor by fluorescence resonance energy transfer assay,Confirmatory,10956205.0,
67,74526,4,6,,103542516,10133,Unspecified,,,,,Inhibition of glucuronosyltransferase activity in the human colon cancer cell line HT-29 at 5 uM concentration,Other,,
68,240134,10,5,,103542516,10133,Active,46577705.0,9971.0,30.0,EC50,Activation of human farnesoid X receptor; range is 10-30,Confirmatory,16107136.0,
69,240176,10,5,,103542516,10133,Active,46577705.0,9971.0,8.66,EC50,Binding affinity for human Farnesoid X receptor in FRET assay,Confirmatory,15317466.0,
70,240314,10,5,,103542516,10133,Active,46577705.0,9971.0,3.5,EC50,Effective concentration for recruitment of SRC-1 LxxLL-containing peptide to human Farnesoid X receptor,Confirmatory,16107136.0,
71,243397,3,10,,103542516,10133,Unspecified,46577705.0,9971.0,,,Efficacy for human Farnesoid X receptor in FRET assay,Other,15317466.0,
72,265705,7,6,,103542516,10133,Active,46577705.0,9971.0,11.7,EC50,Agonist activity at human recombinant FXR by transactivation of TK-MH100x4-LUC reporter gene in HEK293 cells,Confirmatory,16617018.0,
73,267784,7,6,,103542516,10133,Unspecified,46577705.0,9971.0,,EC50,Binding affinity to FXR assessed as ligand-dependent SRC1 recruitment by FRET based co-activator assay,Confirmatory,16821780.0,
74,269847,3,10,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at FXR in HepG2 cells by luciferase activity relative to DMSO at 10 uM,Other,16784849.0,
75,294203,7,6,,103542516,10133,Active,46577705.0,9971.0,27.0,EC50,Agonistic activity at FXR in HEK293 cells by GAL4 transactivation activity,Confirmatory,17292610.0,
76,294206,3,10,,103542516,10133,Inactive,46577705.0,9971.0,,,Inhibition of FXR in HEK293 cells in presence of CDCA at 100 uM by GAL4 transactivation activity,Other,17292610.0,
77,297449,3,7,,103542516,10133,Unspecified,74762624.0,151306.0,,,Agonist activity at human TGR5 expressed in CHO cells after 5 hrs by CRE-driven luciferase reporter gene assay relative to lithocholic acid,Other,17685603.0,
78,297450,7,1,,103542516,10133,Active,74762624.0,151306.0,6.71,EC50,Agonist activity at human TGR5 expressed in CHO cells after 5 hrs by CRE-driven luciferase reporter gene assay,Confirmatory,17685603.0,
79,297451,7,6,,103542516,10133,Active,46577705.0,9971.0,13.0,EC50,Agonist activity at human FXR expressed in COS1 cells after 5 hrs by CRE-driven luciferase reporter gene assay,Confirmatory,17685603.0,
80,297452,4,10,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human FXR expressed in COS1 cells after 5 hrs by CRE-driven luciferase reporter gene assay relative to 6ECDCA,Other,17685603.0,
81,297453,3,5,,103542516,10133,Unspecified,,,,,Ratio of EC50 for TGR5 expressed in CHO cells to EC50 for FXR expressed in COS1 cells,Other,17685603.0,
82,303492,3,10,,103542516,10133,Active,6093860.0,8856.0,,,Activation of human PXR expressed in HEK293 cells at 20 uM by GAL4 activation assay relative to control,Other,17963371.0,
83,303493,3,10,,103542516,10133,Active,6093860.0,8856.0,,,Activation of human PXR expressed in HEK293 cells at 50 uM by GAL4 activation assay relative to control,Other,17963371.0,
84,303494,3,10,,103542516,10133,Inactive,46577705.0,9971.0,,,Antagonist activity at human FXR expressed in HEK293 cells assessed as inhibition of GW-4064-induced response at 100 uM by GAL4 activation assay,Other,17963371.0,
85,303496,3,10,,103542516,10133,Active,46577705.0,9971.0,,,Activity at human VP16-FXR assessed as activation of SRC1 interaction domain 2 recruitment at 50 uM by mammalian two-hybrid assay,Other,17963371.0,
86,303498,3,5,,103542516,10133,Unspecified,,,,,Activation of human FXR/RXRalpha heterodimer at 50 uM by FXRE TK-luciferase reporter gene assay relative to control,Other,17963371.0,
87,303500,3,3,,103542516,10133,Active,,,,,Activation of BSEP gene expression in human Huh7 cells at 20 uM after 18 hrs by RT-PCR,Other,17963371.0,
88,303502,3,4,,103542516,10133,Active,,,,,Activation of BSEP gene expression in human HepG2 cells at 25 uM after 18 hrs by RT-PCR,Other,17963371.0,
89,303504,3,3,,103542516,10133,Active,,,,,Activation of SHP gene expression in human Huh7 cells at 20 uM after 18 hrs by RT-PCR,Other,17963371.0,
90,303505,3,4,,103542516,10133,Active,,,,,Activation of SHP gene expression in human HepG2 cells at 25 uM after 18 hrs by RT-PCR,Other,17963371.0,
91,303508,3,4,,103542516,10133,Active,,,,,Decrease in CYP7A1 gene expression in human HepG2 cells at 25 uM after 18 hrs by RT-PCR,Other,17963371.0,
92,303511,3,4,,103542516,10133,Active,,,,,Activation of IBABP gene expression in human Caco-2 cells at 25 uM after 6 days by RT-PCR,Other,17963371.0,
93,303512,3,10,,103542516,10133,Active,74762624.0,151306.0,,,Activation of TGR5 expressed in HEK293 cells assessed as elevation of cAMP production at 10 uM relative to control,Other,17963371.0,
94,324923,7,6,,103542516,10133,Active,74762624.0,151306.0,6.71,EC50,Agonist activity at human TGR5 expressed in CHO cells by luciferase assay,Confirmatory,18307294.0,
95,324924,3,10,,103542516,10133,Unspecified,74762624.0,151306.0,,,Agonist activity at human TGR5 expressed in CHO cells by luciferase assay relative to lithocholic acid,Other,18307294.0,
96,324925,7,6,,103542516,10133,Active,46577705.0,9971.0,13.0,EC50,Agonist activity at human FXR expressed in COS1 cells by luciferase assay,Confirmatory,18307294.0,
97,324926,3,10,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity against human FXR expressed in COS1 cells by luciferase assay relative to 6-enantiomeric chenodeoxy cholic acid,Other,18307294.0,
98,324927,3,3,,103542516,10133,Unspecified,,,,,"Selectivity index, ratio of EC50 for human TGR5 to EC50 for human FXR",Other,18307294.0,
99,346025,3,3,,103542516,10133,Unspecified,,,,,Binding affinity to beta cyclodextrin,Other,19056282.0,
100,388375,3,8,,103542516,10133,Unspecified,,,,,Agonist activity at FXR assessed as activation by cell based luciferase transactivation assay at 10 uM,Other,18815030.0,
101,388376,6,4,,103542516,10133,Active,,,6.31,EC50,Agonist activity at FXR assessed as activation by cell based luciferase transactivation assay,Confirmatory,18815030.0,
102,404304,3,10,,103542516,10133,Unspecified,308153583.0,1244.0,,,Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control,Other,18457386.0,
103,409876,3,4,,103542516,10133,Inactive,,,,,Cytotoxicity against human GBM cells at 50 uM after 24 hrs by neutral red uptake assay,Other,18768321.0,
104,409877,8,1,,103542516,10133,Unspecified,,,50.0,LD50,Cytotoxicity against human GBM cells after 24 hrs by neutral red uptake assay,Confirmatory,18768321.0,
105,409878,8,1,,103542516,10133,Unspecified,,,50.0,LD50,Cytotoxicity against human HCT116 cells after 24 hrs by neutral red uptake assay,Confirmatory,18768321.0,
106,409879,8,1,,103542516,10133,Unspecified,,,50.0,LD50,Cytotoxicity against human KMS11 cells after 24 hrs by neutral red uptake assay,Confirmatory,18768321.0,
107,409880,3,4,,103542516,10133,Inactive,,,,,Cytotoxicity against human HCT116 cells at 50 uM after 24 hrs by neutral red uptake assay,Other,18768321.0,
108,409881,3,4,,103542516,10133,Inactive,,,,,Cytotoxicity against human KMS11 cells at 50 uM after 24 hrs by neutral red uptake assay,Other,18768321.0,
109,409882,3,4,,103542516,10133,Inactive,,,,,Cytotoxicity against human GBM cells at 50 uM after 48 hrs by neutral red uptake assay,Other,18768321.0,
110,409883,3,4,,103542516,10133,Inactive,,,,,Cytotoxicity against human HCT116 cells at 50 uM after 48 hrs by neutral red uptake assay,Other,18768321.0,
111,409884,3,4,,103542516,10133,Inactive,,,,,Cytotoxicity against human KMS11 cells at 50 uM after 48 hrs by neutral red uptake assay,Other,18768321.0,
112,409889,3,4,,103542516,10133,Active,,,,,Cytotoxicity against human GBM cells at 25 uM after 24 hrs by neutral red uptake assay,Other,18768321.0,
113,409890,3,4,,103542516,10133,Active,,,,,Cytotoxicity against human HCT116 cells at 25 uM after 24 hrs by neutral red uptake assay,Other,18768321.0,
114,409891,3,4,,103542516,10133,Active,,,,,Cytotoxicity against human KMS11 cells at 25 uM after 24 hrs by neutral red uptake assay,Other,18768321.0,
115,422543,3,10,,103542516,10133,Unspecified,129404.0,5319.0,,,"Reduction in human pancreatic recombinant 1B PLA2 activity expressed in Escherichia coli assessed as hydrolysis of 1,2-dimyristoyl-sn-3-glycerophosphocholine vesicles at 0.03 mol fraction relative to cholate",Other,19102680.0,
116,422544,3,10,,103542516,10133,Unspecified,129404.0,5319.0,,,"Reduction in human pancreatic recombinant 1B PLA2 activity expressed in Escherichia coli assessed as hydrolysis of 1,2-dimyristoyl-sn-3-glycerophosphocholine vesicles at 0.007 mol fraction relative to cholate",Other,19102680.0,
117,422552,3,10,,103542516,10133,Active,129404.0,5319.0,,,Binding affinity to human pancreatic recombinant 1B PLA2 expressed in Escherichia coli at 100 uM by saturation transfer difference NMR spectroscopy,Other,19102680.0,
118,422553,3,3,,103542516,10133,Active,,,,,Binding affinity to pig PLA2 at 100 uM by saturation transfer difference NMR spectroscopy,Other,19102680.0,
119,422554,3,11,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human FXR transfected in human HuH7 cells co-transfected with human BSEP promoter reporter plasmid at 10 uM after 30 hrs by dual-luciferase reporter assay relative to control,Other,19102680.0,
120,422555,3,11,,103542516,10133,Unspecified,46577705.0,9971.0,,,Antagonist activity at human FXR transfected in human HuH7 cells co-transfected with human BSEP promoter reporter plasmid at 10 uM after 30 hrs by dual-luciferase reporter assay relative to chenodeoxycholate,Other,19102680.0,
121,422556,3,7,,103542516,10133,Active,,,,,Enhancement of bile salt export pump promoter transactivation,Other,19102680.0,
122,434955,1,2,,56463362,10133,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
123,434962,1,2,,56463362,10133,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
124,434973,1,3,,56463362,10133,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
125,434989,1,1,,56463362,10133,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
126,435003,1,3,,56463362,10133,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
127,435005,1,1,,56463362,10133,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
128,435022,2,2,,56463362,10133,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
129,435030,1,2,,56463362,10133,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
130,435030,1,2,,56463362,10133,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
131,441572,8,3,,103542516,10133,Active,,,13.0,EC50,Agonist activity at FXR expressed in COS1 cells by cell-based bioluminescence assay,Confirmatory,20014870.0,
132,441576,6,2,,103542516,10133,Active,,,,,Solubility in 0.1M HCl water solution,Other,20014870.0,
133,441577,3,3,,103542516,10133,Unspecified,,,,,Critical micellar concentration in 0.15 M NaCl water solution,Other,20014870.0,
134,441578,3,7,,103542516,10133,Unspecified,,,,,Binding affinity to albumin,Other,20014870.0,
135,441579,7,1,,103542516,10133,Unspecified,,,,,Metabolic stability in bile fistula rat model assessed as intact drug level recovered in bile at 1 umol/min/kg administered intraduodenally over 1 hr,Other,20014870.0,
136,441580,7,1,,103542516,10133,Unspecified,,,,,Metabolic stability in bile fistula rat model assessed as conjugated drug level recovered in bile at 1 umol/min/kg administered intraduodenally over 1 hr,Other,20014870.0,
137,441581,8,1,,103542516,10133,Unspecified,,,,,"Cholerectic effect in bile fistula rat model assessed as maximum bile secretion rate at 1 umol/min/kg, iv over 1 hr",Other,20014870.0,
138,441582,8,1,,103542516,10133,Unspecified,,,,,"Cholerectic effect in bile fistula rat model assessed as maximum bile acids secretion rate per kg body weight at 1 umol/min/kg, iv over 1 hr",Other,20014870.0,
139,441583,8,1,,103542516,10133,Unspecified,,,,,Cholerectic effect in bile fistula rat model assessed as maximum bile secretion rate at 1 umol/min/kg administered intraduodenally over 1 hr,Other,20014870.0,
140,441584,8,1,,103542516,10133,Unspecified,,,,,Cholerectic effect in bile fistula rat model assessed as maximum bile acids secretion rate per kg body weight at 1 umol/min/kg administered intraduodenally over 1 hr,Other,20014870.0,
141,441585,7,1,,103542516,10133,Unspecified,,,,,"Metabolic stability in bile fistula rat model assessed as intact drug level recovered in bile at 1 umol/min/kg, iv over 1 hr",Other,20014870.0,
142,441586,7,1,,103542516,10133,Unspecified,,,,,"Metabolic stability in bile fistula rat model assessed as conjugated drug level recovered in bile at 1 umol/min/kg, iv over 1 hr",Other,20014870.0,
143,449728,1,2,,56463362,10133,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
144,449762,1,2,,56463362,10133,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
145,449763,1,3,,56463362,10133,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
146,463079,1,2,,56463362,10133,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
147,463082,1,1,,56463362,10133,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
148,463104,1,2,,56463362,10133,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
149,463141,1,2,,56463362,10133,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
150,463190,1,2,,56463362,10133,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
151,463195,1,2,,56463362,10133,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
152,463210,1,2,,56463362,10133,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
153,463212,1,1,,56463362,10133,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
154,463254,1,1,,56463362,10133,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
155,485270,1,1,,56463362,10133,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
156,485272,1,1,,56463362,10133,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
157,485273,2,1,,56463362,10133,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
158,485275,1,3,,56463362,10133,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
159,485294,1,1,,56463362,10133,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
160,485297,1,1,,56463362,10133,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
161,485298,1,1,,56463362,10133,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
162,485313,1,2,,56463362,10133,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
163,485341,1,1,,56463362,10133,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
164,485344,1,1,,56463362,10133,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
165,485346,1,1,,56463362,10133,Inactive,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
166,485346,1,1,,56463362,10133,Inactive,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
167,485347,1,2,,56463362,10133,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
168,485349,1,1,,56463362,10133,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
169,485350,1,2,,92125156,10133,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
170,485353,2,1,,56463362,10133,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
171,485358,1,1,,56463362,10133,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
172,485360,1,1,,56463362,10133,Inactive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
173,485364,1,1,,56463362,10133,Inactive,15149312.0,8345881.0,,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
174,485367,1,2,,56463362,10133,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
175,488837,1,1,,56463362,10133,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
176,488839,1,1,,56463362,10133,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
177,488839,1,1,,56463362,10133,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
178,488847,1,3,,56463362,10133,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
179,488862,1,1,,56463362,10133,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
180,488890,1,2,,56463362,10133,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
181,488895,1,2,,56463362,10133,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
182,488896,1,1,,56463362,10133,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
183,488899,1,1,,56463362,10133,Inactive,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
184,488965,1,2,,56463362,10133,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
185,488966,1,1,,56463362,10133,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
186,488975,1,2,,56463362,10133,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
187,488977,1,2,,56463362,10133,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
188,489030,2,1,,56463362,10133,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
189,489031,2,1,,56463362,10133,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
190,490121,5,3,,103542516,10133,Unspecified,,,50.0,IC50,Cytotoxicity against human KMS11 cells after 24 hrs by neutral red uptake assay,Confirmatory,20381215.0,
191,490122,5,2,,103542516,10133,Unspecified,,,50.0,IC50,Cytotoxicity against human GBM cells after 24 hrs by neutral red uptake assay,Confirmatory,20381215.0,
192,490123,5,2,,103542516,10133,Unspecified,,,50.0,IC50,Cytotoxicity against human HCT116 cells after 24 hrs by neutral red uptake assay,Confirmatory,20381215.0,
193,490124,3,3,,103542516,10133,Unspecified,,,,,"Lipophilicity, log P of the compound",Other,20381215.0,
194,492947,1,1,,56463362,10133,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
195,492953,1,1,,56463362,10133,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
196,492956,1,1,,56463362,10133,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
197,492967,1,2,,92125156,10133,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
198,492972,1,1,,56463362,10133,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
199,493005,1,1,,56463362,10133,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
200,493008,1,1,,56463362,10133,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
201,493008,1,1,,56463362,10133,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
202,493008,1,1,,56463362,10133,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
203,493008,1,1,,56463362,10133,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
204,493011,1,1,,56463362,10133,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
205,493012,1,1,,56463362,10133,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
206,493014,1,1,,56463362,10133,Inconclusive,,,25.929000000000002,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
207,493033,1,2,,92125156,10133,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
208,493036,1,2,,56463362,10133,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
209,493056,1,1,,56463362,10133,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
210,493084,1,1,,56463362,10133,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
211,493087,1,1,,56463362,10133,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
212,493091,1,1,,56463362,10133,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
213,493098,1,1,,56463362,10133,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
214,493131,1,1,,56463362,10133,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
215,493140,1,1,,103914020,10133,Inactive,,,,,Screening small molecules to find regulators of human embryonic stem cell survival.,Screening,,
216,493160,1,1,,56463362,10133,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
217,493187,1,2,,56463362,10133,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
218,493244,1,1,,56463362,10133,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
219,493244,1,1,,56463362,10133,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
220,493244,1,1,,56463362,10133,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
221,493244,1,1,,56463362,10133,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
222,504326,1,2,,56463362,10133,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
223,504326,1,2,,56463362,10133,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
224,504327,1,1,,56463362,10133,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
225,504329,1,1,,56463362,10133,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
226,504332,1,1,,56463362,10133,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
227,504333,1,1,,56463362,10133,Inactive,6683500.0,29994.0,,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
228,504339,1,1,,56463362,10133,Inactive,162330054.0,,,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
229,504357,1,1,,56463362,10133,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
230,504357,1,1,,56463362,10133,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
231,504406,1,1,,56463362,10133,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
232,504411,1,1,,56463362,10133,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
233,504414,1,1,,56463362,10133,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
234,504414,1,1,,56463362,10133,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
235,504423,1,1,,56463362,10133,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
236,504441,1,1,,56463362,10133,Inactive,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
237,504444,1,1,,56463362,10133,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
238,504454,1,3,,56463362,10133,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
239,504462,1,1,,56463362,10133,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
240,504466,1,1,,56463362,10133,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
241,504467,1,1,,56463362,10133,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
242,504490,1,2,,56463362,10133,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
243,504523,1,1,,56463362,10133,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
244,504523,1,1,,56463362,10133,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
245,504558,1,1,,56463362,10133,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
246,504577,2,2,,56463362,10133,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
247,504582,2,1,,56463362,10133,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
248,504621,1,1,,56463362,10133,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
249,504634,1,1,,56463362,10133,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
250,504648,1,1,,56463362,10133,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
251,504651,1,1,,56463362,10133,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
252,504652,1,1,,56463362,10133,Inactive,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
253,504660,1,1,,56463362,10133,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
254,504690,1,3,,56463362,10133,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
255,504692,2,2,,56463362,10133,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
256,504700,1,1,,56463362,10133,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
257,504700,1,1,,56463362,10133,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
258,504706,1,1,,56463362,10133,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
259,504707,1,1,,56463362,10133,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
260,504707,1,1,,56463362,10133,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
261,504720,1,1,,56463362,10133,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
262,504734,1,1,,56463362,10133,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
263,504766,2,1,,56463362,10133,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
264,504775,1,1,,56463362,10133,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
265,504803,1,1,,56463362,10133,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
266,504810,1,2,,56463362,10133,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
267,504812,1,2,,56463362,10133,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
268,504832,1,1,,56463362,10133,Inconclusive,,,18.526,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
269,504834,1,1,,56463362,10133,Inconclusive,,,8.2753,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
270,504842,1,1,,56463362,10133,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
271,504845,1,1,,56463362,10133,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
272,504847,1,1,,56463362,10133,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
273,504884,1,2,,56463362,10133,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
274,504891,1,1,,56463362,10133,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
275,504894,1,1,,56463362,10133,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
276,504937,1,2,,56463362,10133,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
277,515398,4,3,,103542516,10133,Unspecified,,,216.0,CC50,Cytotoxicity against human HET-1A cells assessed as cell viability after 24 hrs by MTT assay,Confirmatory,20713311.0,
278,515399,2,5,,103542516,10133,Unspecified,,,,,Cytotoxicity against human HuH7 cells assessed as cell viability at 500 uM after 24 hrs by MTT assay relative to control,Other,20713311.0,
279,515400,2,5,,103542516,10133,Unspecified,,,,,Cytotoxicity against human HET-1A cells assessed as cell viability at 500 uM after 24 hrs by MTT assay relative to control,Other,20713311.0,
280,540253,1,1,,56463362,10133,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
281,540253,1,1,,56463362,10133,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
282,540253,1,1,,56463362,10133,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
283,540263,1,1,,56463362,10133,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
284,540263,1,1,,56463362,10133,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
285,540267,1,1,,56463362,10133,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
286,540275,1,1,,56463362,10133,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
287,540277,1,1,,56463362,10133,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
288,540295,1,1,,56463362,10133,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
289,540299,1,2,,92125156,10133,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
290,540303,1,1,,56463362,10133,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
291,540303,1,1,,56463362,10133,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
292,540303,1,1,,56463362,10133,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
293,540308,1,1,,56463362,10133,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
294,540317,1,1,,56463362,10133,Inactive,187960037.0,10951.0,100.0,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
295,540336,1,1,,56463362,10133,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
296,540336,1,1,,56463362,10133,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
297,540364,1,2,,56463362,10133,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
298,587931,2,6,,103542516,10133,Inactive,,,,,Agonist activity at FXR expressed in human HepG2 cells assessed as beta-galactosidase activity at 10 uM after 18 hrs by luminometric analysis,Other,21309576.0,
299,587932,3,5,,103542516,10133,Active,,,,,Antagonist activity at FXR expressed in human HepG2 cells assessed as inhibition of CDCA-induced transactivation of FXR at 50 uM after 18 hrs by luminometric analysis,Other,21309576.0,
300,587939,2,6,,103542516,10133,Active,,,,,Activation of FXR expressed in human HepG2 cells assessed as dissociation of NCoR from OSTalpha promoter at 50 uM after 18 hrs by chromatin immunoprecipitation,Other,21309576.0,
301,588209,2,3,,103542516,10133,Unspecified,,,,,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,Other,20553011.0,
302,588210,2,4,,103542516,10133,Unspecified,,,,,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,Other,20843939.0,
303,588211,2,3,,103542516,10133,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",Other,20014752.0,
304,588212,2,3,,103542516,10133,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",Other,20014752.0,
305,588213,2,3,,103542516,10133,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",Other,20014752.0,
306,588214,2,3,,103542516,10133,Unspecified,,,,,"FDA HLAED, liver enzyme composite activity",Other,16472241.0,
307,588215,2,3,,103542516,10133,Unspecified,,,,,"FDA HLAED, alkaline phosphatase increase",Other,16472241.0,
308,588216,2,3,,103542516,10133,Unspecified,,,,,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",Other,16472241.0,
309,588217,2,3,,103542516,10133,Unspecified,,,,,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",Other,16472241.0,
310,588218,2,3,,103542516,10133,Unspecified,,,,,"FDA HLAED, lactate dehydrogenase (LDH) increase",Other,16472241.0,
311,588219,2,3,,103542516,10133,Unspecified,,,,,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",Other,16472241.0,
312,588334,1,1,,56463362,10133,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
313,588335,1,1,,56463362,10133,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
314,588342,1,1,,56463362,10133,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
315,588352,1,2,,56463362,10133,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
316,588354,1,1,,56463362,10133,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
317,588358,1,2,,56463362,10133,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
318,588391,1,1,,56463362,10133,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
319,588405,1,1,,56463362,10133,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
320,588413,1,2,,56463362,10133,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
321,588436,1,1,,56463362,10133,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
322,588453,1,1,,56463362,10133,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
323,588456,1,1,,56463362,10133,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
324,588458,1,1,,56463362,10133,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
325,588473,1,1,,56463362,10133,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
326,588473,1,1,,56463362,10133,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
327,588475,1,2,,56463362,10133,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
328,588475,1,2,,56463362,10133,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
329,588478,1,2,,124800888,10133,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
330,588489,1,1,,56463362,10133,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
331,588492,1,1,,56463362,10133,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
332,588493,1,2,,56463362,10133,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
333,588497,1,2,,56463362,10133,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
334,588497,1,2,,56463362,10133,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
335,588497,1,2,,56463362,10133,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
336,588499,1,3,,56463362,10133,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
337,588499,1,3,,56463362,10133,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
338,588499,1,3,,56463362,10133,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
339,588501,1,2,,56463362,10133,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
340,588501,1,2,,56463362,10133,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
341,588501,1,2,,56463362,10133,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
342,588511,1,2,,56463362,10133,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
343,588519,1,2,,92125156,10133,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
344,588549,1,1,,56463362,10133,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
345,588579,1,1,,56463362,10133,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
346,588590,1,1,,56463362,10133,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
347,588591,1,1,,56463362,10133,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
348,588621,1,1,,56463362,10133,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
349,588627,1,1,,56463362,10133,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
350,588664,1,2,,56463362,10133,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
351,588664,1,2,,56463362,10133,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
352,588674,1,2,,56463362,10133,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
353,588675,1,1,,56463362,10133,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
354,588676,1,1,,56463362,10133,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
355,588689,1,1,,56463362,10133,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
356,588692,2,1,,56463362,10133,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
357,588726,1,2,,56463362,10133,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
358,588727,1,1,,56463362,10133,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
359,588795,1,1,,56463362,10133,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
360,588814,1,3,,56463362,10133,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
361,588819,1,4,,56463362,10133,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
362,588834,2,1,,144203963,10133,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
363,588850,1,1,,56463362,10133,Inactive,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
364,588852,1,3,,56463362,10133,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
365,588855,1,1,,56463362,10133,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
366,588856,1,1,,56463362,10133,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
367,592913,6,5,,103542516,10133,Active,46577705.0,9971.0,21.0,EC50,Agonist activity at human GST-fused FXR LBD assessed as coactivator interaction with receptor ligand binding domain by Alphascreen assay,Confirmatory,21459580.0,
368,592917,4,6,,103542516,10133,Active,74762624.0,151306.0,30.0,EC50,Agonist activity at human TGR5 receptor expressed in NCI-H716 cells assessed as intracellular cAMP level by TR-FRET assay,Confirmatory,21459580.0,
369,592918,1,10,,103542516,10133,Active,46577705.0,9971.0,,,Induction of FXR-mediated SHP mRNA expression in human HepG2 cells at 20 uM by RT-PCR,Other,21459580.0,
370,592919,1,10,,103542516,10133,Active,46577705.0,9971.0,,,Induction of FXR-mediated SHP mRNA expression in human HepG2 cells at 1 uM by RT-PCR,Other,21459580.0,
371,592920,1,10,,103542516,10133,Active,46577705.0,9971.0,,,Induction of FXR-mediated BSEP mRNA expression in human HepG2 cells at 20 uM by RT-PCR,Other,21459580.0,
372,592921,1,10,,103542516,10133,Active,46577705.0,9971.0,,,Induction of FXR-mediated BSEP mRNA expression in human HepG2 cells at 1 uM by RT-PCR,Other,21459580.0,
373,592922,1,10,,103542516,10133,Active,46577705.0,9971.0,,,Induction of FXR-mediated Ostbeta mRNA expression in human HepG2 cells at 20 uM by RT-PCR,Other,21459580.0,
374,592923,1,10,,103542516,10133,Active,46577705.0,9971.0,,,Induction of FXR-mediated Ostbeta mRNA expression in human HepG2 cells at 1 uM by RT-PCR,Other,21459580.0,
375,592924,1,11,,103542516,10133,Active,46577705.0,9971.0,,,Induction of FXR-mediated down-regulation of Cyp7A1 mRNA expression in human HepG2 cells at 1 uM by RT-PCR,Other,21459580.0,
376,592925,1,11,,103542516,10133,Active,46577705.0,9971.0,,,Induction of FXR-mediated down-regulation of Cyp7A1 mRNA expression in human HepG2 cells at 20 uM by RT-PCR,Other,21459580.0,
377,602123,1,1,,56463362,10133,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
378,602141,1,1,,56463362,10133,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
379,602162,1,1,,56463362,10133,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
380,602163,1,1,,56463362,10133,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
381,602179,1,2,,56463362,10133,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
382,602229,1,1,,56463362,10133,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
383,602233,1,1,,56463362,10133,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
384,602244,1,2,,56463362,10133,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
385,602247,1,2,,56463362,10133,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
386,602248,1,2,,56463362,10133,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
387,602250,1,2,,56463362,10133,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
388,602252,1,1,,56463362,10133,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
389,602252,1,1,,56463362,10133,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
390,602261,1,1,,56463362,10133,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
391,602274,1,2,,56463362,10133,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
392,602281,1,1,,56463362,10133,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
393,602281,1,1,,56463362,10133,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
394,602310,1,2,,56463362,10133,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
395,602313,1,1,,56463362,10133,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
396,602314,1,2,,92125156,10133,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
397,602329,1,1,,56463362,10133,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
398,602332,1,1,,56463362,10133,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
399,602340,1,2,,56463362,10133,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
400,602342,2,1,,56463362,10133,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
401,602346,1,1,,56463362,10133,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
402,602363,1,1,,56463362,10133,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
403,602393,1,1,,56463362,10133,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
404,602396,1,2,,56463362,10133,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
405,602399,1,2,,56463362,10133,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
406,602405,1,1,,56463362,10133,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
407,602410,1,1,,56463362,10133,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
408,602429,1,1,,56463362,10133,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
409,602438,1,1,,56463362,10133,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
410,602440,1,1,,56463362,10133,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
411,602449,1,2,,56463362,10133,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
412,602481,1,1,,56463362,10133,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
413,623870,1,1,,56463362,10133,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
414,623870,1,1,,56463362,10133,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
415,623877,1,1,,56463362,10133,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
416,623901,1,1,,56463362,10133,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
417,624037,1,3,,56463362,10133,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
418,624038,1,3,,56463362,10133,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
419,624040,1,3,,56463362,10133,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
420,624125,1,4,,56463362,10133,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
421,624126,1,3,,56463362,10133,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
422,624127,1,2,,56463362,10133,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
423,624168,1,1,,56463362,10133,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
424,624169,1,1,,56463362,10133,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
425,624170,1,1,,56463362,10133,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
426,624171,1,1,,56463362,10133,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
427,624172,1,1,,56463362,10133,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
428,624173,1,3,,56463362,10133,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
429,624178,1,1,,56463362,10133,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
430,624202,1,1,,56463362,10133,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
431,624204,1,2,,56463362,10133,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
432,624246,1,1,,56463362,10133,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
433,624256,1,2,,56463362,10133,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
434,624263,1,1,,56463362,10133,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
435,624263,1,1,,56463362,10133,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
436,624267,1,2,,56463362,10133,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
437,624267,1,2,,56463362,10133,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
438,624268,1,3,,56463362,10133,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
439,624288,1,1,,56463362,10133,Inconclusive,52000961.0,2778.0,31.6228,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
440,624296,1,1,,56463362,10133,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
441,624297,1,1,,56463362,10133,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
442,624304,1,2,,56463362,10133,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
443,624330,1,2,,56463362,10133,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
444,624349,1,2,,92125156,10133,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
445,624349,1,2,,121362827,10133,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
446,624352,1,1,,56463362,10133,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
447,624354,1,1,,56463362,10133,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
448,624377,1,1,,56463362,10133,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
449,624414,1,1,,56463362,10133,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
450,624415,1,2,,56463362,10133,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
451,624416,1,1,,56463362,10133,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
452,624417,1,1,,56463362,10133,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
453,624418,1,1,,56463362,10133,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
454,624463,1,1,,56463362,10133,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
455,624464,1,1,,56463362,10133,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
456,624465,1,1,,56463362,10133,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
457,624466,1,3,,56463362,10133,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
458,624467,1,1,,56463362,10133,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
459,624483,1,1,,56463362,10133,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
460,624618,3,2,,103542516,10133,Unspecified,6175083.0,7363.0,,,Specific activity of expressed human recombinant UGT2B4,Other,10836148.0,
461,625295,1,3,,103542516,10133,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) validation dataset; compound DILI positive/negative as observed in Pfizer data,Other,22194678.0,
462,629055,3,3,,103542516,10133,Active,,,10.0,EC50,Agonist activity at FXR,Confirmatory,22014750.0,
463,629056,1,4,,103542516,10133,Unspecified,,,,,Agonist activity at full length mouse FXR/RXRalpha expressed in human HEK293 cells assessed as induction of transcriptional activity at 10 ug/mL after 18 hrs by dual luciferase reporter gene assay relative to control,Other,22014750.0,
464,629057,1,9,,103542516,10133,Active,46577705.0,9971.0,,,Agonist activity at FXR in human HepG2 cells assessed as inhibition of CYP7A1 mRNA expression at 50 uM for 6 hrs by RT-PCR relative to control,Other,22014750.0,
465,629094,3,2,,103542516,10133,Active,,,16.8,EC50,Agonist activity at full length mouse FXR/RXRalpha expressed in human HEK293 cells assessed as induction of transcriptional activity after 18 hrs by dual luciferase reporter gene assay,Confirmatory,22014750.0,
466,635573,4,6,,103542516,10133,Active,341942230.0,20186.0,16.8,EC50,Agonist activity at mouse FXR expressed in HEK293 cells co-expressing mouse RXRalpha and ECRE-luc by luciferase reporter gene assay,Confirmatory,22018919.0,
467,635574,1,9,,103542516,10133,Active,46577705.0,9971.0,,,Agonist activity at FXR in human HepG2 cells assessed as decrease in CYP7A1 mRNA expression at 50 uM after 6 hrs by quantitative PCR analysis,Other,22018919.0,
468,645565,1,6,,103542516,10133,Active,46577705.0,9971.0,,,Agonist activity at FXR in human HepG2 cells at 10 uM after 48 hrs by luciferase reporter gene based transactivation assay,Other,22126372.0,
469,651550,1,1,,56463362,10133,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
470,651560,1,1,,56463362,10133,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
471,651572,1,2,,56463362,10133,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
472,651582,1,1,,56463362,10133,Inactive,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
473,651602,1,1,,56463362,10133,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
474,651602,1,1,,56463362,10133,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
475,651602,1,1,,56463362,10133,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
476,651610,2,1,,56463362,10133,Inactive,,,,,HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
477,651631,4,1,,144203963,10133,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
478,651631,4,1,,144207689,10133,Inconclusive,269849759.0,7157.0,68.7989,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
479,651632,4,1,,144203963,10133,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
480,651632,4,1,,144207689,10133,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
481,651633,4,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
482,651633,4,1,,144207689,10133,Inconclusive,,,68.7989,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
483,651634,4,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
484,651634,4,1,,144207689,10133,Inconclusive,,,77.1937,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
485,651635,1,3,,56463362,10133,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
486,651636,1,1,,56463362,10133,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
487,651640,1,1,,56463362,10133,Inconclusive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
488,651644,1,1,,56463362,10133,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
489,651647,1,1,,56463362,10133,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
490,651654,1,1,,56463362,10133,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
491,651658,1,1,,56463362,10133,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
492,651661,2,1,,56463362,10133,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
493,651699,1,1,,56463362,10133,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
494,651699,1,1,,56463362,10133,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
495,651702,1,2,,56463362,10133,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
496,651704,2,1,,56463362,10133,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
497,651710,1,1,,56463362,10133,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
498,651711,2,1,,56463362,10133,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
499,651718,1,2,,56463362,10133,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
500,651719,1,2,,56463362,10133,Inactive,4503907.0,8484.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3),Screening,,
501,651724,1,1,,56463362,10133,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
502,651725,1,1,,56463362,10133,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
503,651768,1,2,,56463362,10133,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
504,651800,1,1,,56463362,10133,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
505,651819,1,1,,56463362,10133,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
506,651820,1,1,,56463362,10133,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
507,651821,2,4,,56463362,10133,Active,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
508,651957,1,1,,56463362,10133,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
509,651958,1,1,,56463362,10133,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
510,651965,1,1,,56463362,10133,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
511,651999,1,1,,56463362,10133,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
512,652010,1,1,,56463362,10133,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
513,652017,1,1,,56463362,10133,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
514,652025,1,1,,56463362,10133,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
515,652039,1,1,,56463362,10133,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
516,652048,1,2,,56463362,10133,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
517,652048,1,2,,144203963,10133,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
518,652051,1,1,,56463362,10133,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
519,652051,1,1,,144203963,10133,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
520,652054,1,1,,56463362,10133,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
521,652065,1,1,,56463362,10133,Inactive,,,,,Fluorescence-based biochemical high throughput confirmation assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
522,652067,1,4,,56463362,10133,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
523,652068,1,3,,56463362,10133,Inactive,,,,,Counterscreen for molecules that bind rCAG RNA repeats: fluorescent based biochemical counterscreen assay for inhibitors of the DNA-based (5'CAG/3'GTC) TO-PRO-1 dye complex,Screening,,
524,652104,1,1,,56463362,10133,Active,20140568.0,23435.0,22.3872,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
525,652105,1,1,,56463362,10133,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
526,652106,1,1,,56463362,10133,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
527,652115,1,1,,56463362,10133,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
528,652126,1,3,,56463362,10133,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
529,652154,1,1,,56463362,10133,Inactive,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
530,652162,2,1,,56463362,10133,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
531,652163,1,1,,56463362,10133,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
532,652197,1,1,,56463362,10133,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
533,652257,1,1,,56463362,10133,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
534,657096,1,3,,103542516,10133,Unspecified,,,,,Restoration of human BSEP E297G mutant trafficking to cell membrane in MDCK2 cells co-expressing NTCP assessed as accumulation of [3H]taurocholate at 100 uM preincubated for 24 hrs prior incubation with [3H]taurocholate measured after 2 hrs by liquid scintillation counting,Other,22464344.0,
535,657097,1,3,,103542516,10133,Unspecified,,,,,Restoration of human BSEP E297G mutant trafficking to cell membrane in MDCK2 cells co-expressing NTCP assessed as accumulation of [3H]taurocholate at 10 uM preincubated for 24 hrs prior incubation with [3H]taurocholate measured after 2 hrs by liquid scintillation counting,Other,22464344.0,
536,659710,1,8,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 0.1 uM after 24 hrs by dual-luciferase assay relative to control,Other,22472691.0,
537,659711,1,8,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 1 uM after 24 hrs by dual-luciferase assay relative to control,Other,22472691.0,
538,659712,1,8,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 5 uM after 24 hrs by dual-luciferase assay relative to control,Other,22472691.0,
539,659713,1,8,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 10 uM after 24 hrs by dual-luciferase assay relative to control,Other,22472691.0,
540,659714,1,8,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 25 uM after 24 hrs by dual-luciferase assay relative to control,Other,22472691.0,
541,659715,1,8,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 50 uM after 24 hrs by dual-luciferase assay relative to control,Other,22472691.0,
542,659716,1,8,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human farnesoid X receptor expressed in human HepG2 cells at 100 uM after 24 hrs by dual-luciferase assay relative to control,Other,22472691.0,
543,660287,1,3,,103542516,10133,Active,,,,,Inhibition of osteoclastogenesis in human osteoclasts obtained from PBMC assessed as formation of TRAPC positive multinucleated cells at 10'-5 M after 7 days,Other,22483634.0,
544,660288,1,2,,103542516,10133,Active,,,,,Induction of apoptosis in human multinucleated osteoclasts obtained from PBMC assessed as formation of apoptotic nuclear bodies at 10'-5 M after 7 days by Hoechst 33258 staining,Other,22483634.0,
545,662691,1,3,,103542516,10133,Unspecified,,,,,Enhancement of human BSEP E297G mutant trafficking to cell membrane in MDCK2 cells co-expressing NTCP assessed as accumulation of [3H]taurocholate at 10 uM preincubated for 24 hrs prior incubation with [3H]taurocholate measured after 2 hrs by liquid scintillation counting,Other,22583617.0,
546,662692,3,6,,103542516,10133,Active,46577705.0,9971.0,27.0,EC50,Agonist activity at human recombinant FXR expressed in HEK293 cells coexpressing CMX-GAL4N by luciferase reporter gene assay,Confirmatory,22583617.0,
547,662693,1,8,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human recombinant FXR expressed in HEK293 cells coexpressing CMX-GAL4N by luciferase reporter gene assay relative to GW4064,Other,22583617.0,
548,672332,1,5,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at FXR LBD expressed in human HepG2 cells co-expressing GAL4 DBD and pG5-luc assessed as luciferase activity at 10 uM after 48 hrs by transient transfection reporter assay relative to control,Other,22683342.0,
549,672335,1,5,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at FXR LBD expressed in human HepG2 cells co-expressing GAL4 DBD and pG5-luc assessed as SHP promoter-driven luciferase activity at 10 uM after 48 hrs by transient transfection reporter assay relative to control,Other,22683342.0,
550,672338,1,5,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at FXR LBD expressed in human HepG2 cells co-expressing GAL4 DBD and pG5-luc assessed as transrepression of rat CYP7A1 promoter-driven luciferase activity at 10 uM after 48 hrs by transient transfection reporter assay relative to control,Other,22683342.0,
551,672341,1,5,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at FXR LBD expressed in human HepG2 cells co-expressing GAL4 DBD and pG5-luc assessed as PLTP promoter-driven luciferase activity at 10 uM after 48 hrs by transient transfection reporter assay relative to control,Other,22683342.0,
552,673744,3,1,,103542516,10133,Active,74762624.0,151306.0,6.7,EC50,Agonist activity at TGR5 expressed in NCI-H716 cells assessed as cAMP level after 60 mins by FRET analysis,Confirmatory,24900463.0,
553,673745,1,6,,103542516,10133,Unspecified,74762624.0,151306.0,,,Agonist activity at TGR5 expressed in NCI-H716 cells assessed as cAMP level after 60 mins by FRET analysis relative to 10 uM LCA,Other,24900463.0,
554,673746,3,1,,103542516,10133,Active,46577705.0,9971.0,13.0,EC50,Agonist activity at GST-tagged FXR-LBD using biotinylated-SRC-1 peptide as substrate preincubated with compound for 30 mins measured after 4 hrs,Confirmatory,24900463.0,
555,673747,1,6,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at GST-tagged FXR-LBD using biotinylated-SRC-1 peptide as substrate preincubated with compound for 30 mins measured after 4 hrs relative to 10 uM CDCA,Other,24900463.0,
556,673748,1,3,,103542516,10133,Unspecified,,,,,Critical micelle concentration of the compound in 0.15 M NaCl water solution,Other,24900463.0,
557,673749,1,3,,103542516,10133,Unspecified,,,,,"1-Octanol/water partition coefficient, log P of the compound by conventional shake-flask method",Other,24900463.0,
558,673750,2,3,,103542516,10133,Active,,,,,Aqueous solubility of the compound in 0.1 M HCl water at pH 3 by HPLC-ES-MS/MS,Other,24900463.0,
559,673751,1,6,,103542516,10133,Unspecified,113576.0,213.0,,,Binding affinity to albumin by equilibrium dialysis,Other,24900463.0,
560,679473,1,7,,103542516,10133,Unspecified,262527527.0,8647.0,,,"TP_TRANSPORTER: Western in vitro, primary human hepatocyte",Other,11509573.0,
561,679670,1,8,,103542516,10133,Unspecified,308153583.0,1244.0,,,TP_TRANSPORTER: Northern blot from HepG2 cells,Other,11706036.0,
562,679680,1,7,,103542516,10133,Unspecified,2498046.0,6554.0,,,"TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurochorate: 10 uM, CDCA: 100 uM) in Xenopus laevis oocytes",Other,8132774.0,
563,679712,1,7,,103542516,10133,Unspecified,46576880.0,20494.0,,,"TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurocholate: 0.72 uM, CDCA: a 100-fold excess) in isolated mouse ileocytes",Other,10101301.0,
564,679790,1,7,,103542516,10133,Unspecified,81911503.0,,,,TP_TRANSPORTER: inhibition of Daunomycin uptake in canalicular membrane vesicles,Other,7912687.0,
565,680004,1,8,,103542516,10133,Unspecified,1171882.0,6579.0,,,"TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurochorate: 10 uM, CDCA: 200 uM) in Xenopus laevis oocytes",Other,7557095.0,
566,680037,1,8,,103542516,10133,Unspecified,1171882.0,6579.0,,,"TP_TRANSPORTER: inhibition of BSP uptake (BSP: 10 uM, CDCA: 200 uM) in Xenopus laevis oocytes",Other,7557095.0,
567,680230,1,8,,103542516,10133,Unspecified,1171883.0,50572.0,,,TP_TRANSPORTER: uptake of Chenodeoxycholate at 20 uM in Oatp1-expressing HeLa cells,Other,12842829.0,
568,680256,1,8,,103542516,10133,Unspecified,1171883.0,50572.0,,,"TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurochorate: 20 uM, CDCA: 200 uM) in Xenopus laevis oocytes",Other,8045503.0,
569,680638,1,8,,103542516,10133,Unspecified,1171883.0,50572.0,,,"TP_TRANSPORTER: inhibition of BSP uptake (BSP: 2 uM, CDCA: 100 uM) in Xenopus laevis oocytes",Other,8045503.0,
570,681332,3,6,,103542516,10133,Unspecified,322510055.0,6555.0,3.3,Ki,TP_TRANSPORTER: inhibition of Taurocholate uptake in ASBT-expressing COS cells,Confirmatory,9458785.0,
571,681352,2,2,,103542516,10133,Unspecified,,,,Km,TP_TRANSPORTER: transepithelial transport (basal to apical) in Ntcp/Bsep double transfected MDCK cell,Confirmatory,15297262.0,
572,681660,1,8,,103542516,10133,Unspecified,338817847.0,27413.0,,,"TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurochorate: 5 uM, CDCA: 50 uM) in membrane vesicles isolated from Bsep-expressing Balb-3T3 cells",Other,10607905.0,
573,682019,1,7,,103542516,10133,Unspecified,2811069.0,20493.0,,,"TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurocholate: 0.72 uM, CDCA: 72 uM) in Ntcp-expressing COS-7 cells",Other,12092825.0,
574,682147,1,7,,103542516,10133,Unspecified,127792.0,24777.0,,,"TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurocholate: 5 uM, CDCA: 100 uM) in Ntcp-expressing COS-7 cells",Other,8166278.0,
575,686940,1,1,,56463362,10133,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
576,686964,1,1,,56463362,10133,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
577,686970,1,2,,56463362,10133,Inactive,49168486.0,3417.0,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
578,686971,1,2,,56463362,10133,Inactive,,,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
579,686977,2,1,,49699071,10133,Inactive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
580,686978,1,1,,56463362,10133,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
581,686978,1,1,,144203963,10133,Inconclusive,79154014.0,55775.0,2.2695,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
582,686979,1,1,,56463362,10133,Inconclusive,79154014.0,55775.0,29.0929,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
583,686979,1,1,,144203963,10133,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
584,686992,2,1,,56463362,10133,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
585,686996,1,1,,56463362,10133,Inactive,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
586,687014,1,1,,56463362,10133,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
587,687016,1,1,,56463362,10133,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
588,702678,2,2,,103542516,10133,Active,,,12.5,EC50,Agonist activity at GST tagged human recombinant FXRalphaLBD expressed in Escherichia coli BL21 cells assessed as SRC-1 co-activator association after 30 mins by HTRF assay,Confirmatory,22862148.0,
589,714963,1,7,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human FXR expressed in human HepG2 cells assessed as down-regulation of CYP7A1 gene transactivation at 10 uM by measuring relative luciferase activity by transient transfection reporter assay relative to control,Other,22365756.0,
590,714968,1,7,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human FXR expressed in human HepG2 cells assessed as transactivation of SHP gene by measuring relative luciferase activity by transient transfection reporter assay relative to control,Other,22365756.0,
591,720504,1,1,,56463362,10133,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
592,720508,1,1,,56463362,10133,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
593,720509,1,1,,56463362,10133,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
594,720511,1,1,,56463362,10133,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
595,720516,2,1,,144203963,10133,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
596,720516,2,1,,144207689,10133,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
597,720532,1,1,,144203963,10133,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
598,720533,1,1,,144203963,10133,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
599,720542,1,2,,56463362,10133,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
600,720543,1,1,,56463362,10133,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
601,720551,1,2,,56463362,10133,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
602,720552,2,1,,144203963,10133,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
603,720552,2,1,,144207689,10133,Inconclusive,269849759.0,7157.0,72.8755,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
604,720553,1,2,,56463362,10133,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
605,720579,2,1,,56463362,10133,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
606,720580,1,1,,56463362,10133,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
607,720582,1,1,,56463362,10133,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
608,720596,1,1,,56463362,10133,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
609,720634,2,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
610,720634,2,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
611,720635,2,1,,144203963,10133,Inconclusive,,,0.9023,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
612,720635,2,1,,144207689,10133,Inconclusive,,,27.3893,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
613,720637,2,1,,144203963,10133,Inconclusive,,,3.0222599999999997,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
614,720637,2,1,,144207689,10133,Inconclusive,,,27.3893,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
615,720647,1,2,,56463362,10133,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
616,720648,1,1,,56463362,10133,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
617,720674,2,2,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
618,720674,2,2,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
619,720675,2,2,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
620,720675,2,2,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
621,720678,2,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
622,720678,2,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
623,720679,2,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
624,720679,2,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
625,720680,2,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
626,720680,2,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
627,720681,2,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
628,720681,2,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
629,720682,2,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
630,720682,2,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
631,720683,2,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
632,720683,2,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
633,720684,2,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
634,720684,2,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
635,720685,2,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
636,720685,2,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
637,720686,2,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
638,720686,2,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
639,720687,2,2,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
640,720687,2,2,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
641,720691,4,1,,144203963,10133,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
642,720691,4,1,,144207689,10133,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
643,720692,3,1,,144203963,10133,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
644,720692,3,1,,144207689,10133,Inconclusive,311348376.0,2908.0,61.8334,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
645,720693,3,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
646,720693,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
647,720700,1,4,,56463362,10133,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
648,720702,1,1,,56463362,10133,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
649,720704,1,4,,56463362,10133,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
650,720707,1,2,,56463362,10133,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
651,720708,1,2,,56463362,10133,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
652,720709,1,2,,56463362,10133,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
653,720711,1,2,,56463362,10133,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
654,720717,1,3,,92125156,10133,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
655,720719,2,1,,144203963,10133,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
656,720719,2,1,,144207689,10133,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
657,720725,2,1,,144203963,10133,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
658,720725,2,1,,144207689,10133,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
659,743012,3,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
660,743012,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
661,743014,3,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
662,743014,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
663,743015,3,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
664,743015,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
665,743033,3,1,,144203963,10133,Inconclusive,,,0.0023,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
666,743033,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
667,743035,2,1,,144203963,10133,Inconclusive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
668,743035,2,1,,144207689,10133,Inconclusive,124375976.0,367.0,61.8334,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
669,743036,2,1,,144203963,10133,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
670,743036,2,1,,144207689,10133,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
671,743040,3,1,,144203963,10133,Active,124375976.0,367.0,12.7448,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
672,743040,3,1,,144207689,10133,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
673,743041,3,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
674,743041,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
675,743042,3,1,,144203963,10133,Inactive,124375976.0,367.0,10.1235,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
676,743042,3,1,,144207689,10133,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
677,743053,2,1,,144203963,10133,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
678,743053,2,1,,144207689,10133,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
679,743054,2,1,,144203963,10133,Inconclusive,124375976.0,367.0,10.7234,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
680,743054,2,1,,144207689,10133,Inconclusive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
681,743063,2,1,,144203963,10133,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
682,743063,2,1,,144207689,10133,Inconclusive,124375976.0,367.0,59.5054,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
683,743064,3,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
684,743064,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
685,743065,3,1,,144203963,10133,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
686,743065,3,1,,144207689,10133,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
687,743066,3,1,,144203963,10133,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
688,743066,3,1,,144207689,10133,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
689,743067,2,1,,144203963,10133,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
690,743067,2,1,,144207689,10133,Inconclusive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
691,743069,2,1,,144203963,10133,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
692,743069,2,1,,144207689,10133,Inconclusive,348019627.0,2099.0,49.11600000000001,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
693,743074,2,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
694,743074,2,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
695,743075,2,1,,144203963,10133,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
696,743075,2,1,,144207689,10133,Inactive,348019627.0,2099.0,5.5109,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
697,743077,2,1,,144203963,10133,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
698,743077,2,1,,144207689,10133,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
699,743078,2,1,,144203963,10133,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
700,743078,2,1,,144207689,10133,Inconclusive,348019627.0,2099.0,55.1091,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
701,743079,3,1,,144203963,10133,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
702,743079,3,1,,144207689,10133,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
703,743080,3,1,,144203963,10133,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
704,743080,3,1,,144207689,10133,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
705,743081,3,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
706,743081,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
707,743083,3,1,,144203963,10133,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
708,743083,3,1,,144207689,10133,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
709,743084,3,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
710,743084,3,1,,144207689,10133,Inconclusive,,,77.1937,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
711,743085,3,1,,144203963,10133,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
712,743085,3,1,,144207689,10133,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
713,743086,3,1,,144203963,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
714,743086,3,1,,144207689,10133,Inconclusive,,,68.7989,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
715,743091,2,1,,144203963,10133,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
716,743091,2,1,,144207689,10133,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
717,743094,3,1,,144203963,10133,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
718,743094,3,1,,144207689,10133,Inconclusive,216409692.0,5468.0,7.7844,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
719,743122,2,1,,144203963,10133,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
720,743122,2,1,,144207689,10133,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
721,743126,1,1,,56463362,10133,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
722,743139,2,1,,144203963,10133,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
723,743139,2,1,,144207689,10133,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
724,743140,2,1,,144203963,10133,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
725,743140,2,1,,144207689,10133,Inconclusive,216409692.0,5468.0,29.8234,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
726,743191,3,1,,144207689,10133,Inconclusive,216409692.0,5468.0,24.6163,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
727,743194,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
728,743199,2,1,,144207689,10133,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
729,743202,4,1,,144207689,10133,Inconclusive,20149576.0,4780.0,48.7059,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
730,743203,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
731,743209,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
732,743210,4,1,,144207689,10133,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
733,743211,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
734,743212,3,1,,144207689,10133,Inconclusive,216409690.0,5467.0,27.62,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
735,743213,3,1,,144207689,10133,Inconclusive,,,0.8734,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
736,743215,3,1,,144207689,10133,Inconclusive,216409690.0,5467.0,27.62,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
737,743217,3,1,,144207689,10133,Inconclusive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
738,743218,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
739,743219,3,1,,144207689,10133,Inconclusive,20149576.0,4780.0,54.6489,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
740,743220,3,1,,144207689,10133,Active,325495553.0,9971.0,24.6163,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
741,743221,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
742,743222,3,1,,144207689,10133,Inconclusive,216409708.0,7421.0,43.7747,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
743,743223,3,1,,144207689,10133,Inconclusive,216409708.0,7421.0,39.0142,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
744,743224,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
745,743225,3,1,,144207689,10133,Inconclusive,,,43.7747,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
746,743226,2,1,,144207689,10133,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
747,743227,2,1,,144207689,10133,Inconclusive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
748,743228,3,1,,144207689,10133,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
749,743238,1,1,,56463362,10133,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
750,743239,2,1,,144207689,10133,Active,325495553.0,9971.0,23.6895,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
751,743240,2,1,,144207689,10133,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
752,743241,2,1,,144207689,10133,Inconclusive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
753,743242,2,1,,144207689,10133,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
754,743244,1,1,,144203963,10133,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
755,743247,1,2,,56463362,10133,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
756,743255,1,1,,56463362,10133,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
757,743266,1,2,,56463362,10133,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
758,743269,1,1,,56463362,10133,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
759,743269,1,1,,56463362,10133,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
760,743279,1,2,,56463362,10133,Inactive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
761,743397,1,1,,56463362,10133,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
762,743398,1,1,,56463362,10133,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
763,977599,1,1,,103542516,10133,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
764,977602,1,2,,103542516,10133,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
765,1053197,1,1,,56463362,10133,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
766,1059678,1,2,,103542516,10133,Active,,,,,Agonist activity at TGR5 N76A mutant (unknown origin),Other,24900622.0,
767,1059679,1,2,,103542516,10133,Inactive,,,,,Agonist activity at TGR5 S270A mutant (unknown origin),Other,24900622.0,
768,1059683,1,2,,103542516,10133,Active,,,,,Agonist activity at TGR5 E169A mutant (unknown origin),Other,24900622.0,
769,1059684,1,2,,103542516,10133,Inactive,,,,,Agonist activity at TGR5 N93A mutant (unknown origin),Other,24900622.0,
770,1059685,1,1,,103542516,10133,Unspecified,,,,,Selectivity ratio of EC50 for TGR5 S270A mutant (unknown origin) to EC50 for wild type TGR5 (unknown origin),Other,24900622.0,
771,1059686,1,1,,103542516,10133,Unspecified,,,,,Selectivity ratio of EC50 for TGR5 Y89F mutant (unknown origin) to EC50 for wild type TGR5 (unknown origin),Other,24900622.0,
772,1059687,1,1,,103542516,10133,Unspecified,,,,,Selectivity ratio of EC50 for TGR5 N76A mutant (unknown origin) to EC50 for wild type TGR5 (unknown origin),Other,24900622.0,
773,1059688,1,1,,103542516,10133,Unspecified,,,,,Selectivity ratio of EC50 for TGR5 Y89A mutant (unknown origin) to EC50 for wild type TGR5 (unknown origin),Other,24900622.0,
774,1059689,1,1,,103542516,10133,Unspecified,,,,,Selectivity ratio of EC50 for TGR5 E169A mutant (unknown origin) to EC50 for wild type TGR5 (unknown origin),Other,24900622.0,
775,1059690,2,3,,103542516,10133,Active,74762624.0,151306.0,10.29,EC50,Agonist activity at wild type TGR5 (unknown origin),Confirmatory,24900622.0,
776,1059692,1,1,,103542516,10133,Unspecified,,,,,Selectivity ratio of EC50 for TGR5 N93A mutant (unknown origin) to EC50 for wild type TGR5 (unknown origin),Other,24900622.0,
777,1063178,1,1,,103542516,10133,Inactive,,,,,Induction of necrosis in human Caco2 cells up to 500 uM after 24 hrs by annexin V-FITC/propidium iodide staining-based flow cytometric analysis,Other,24332653.0,
778,1063186,1,1,,103542516,10133,Inactive,,,,,Induction of necrosis in human HT1080 cells up to 500 uM after 24 hrs by annexin V-FITC/propidium iodide staining-based flow cytometric analysis,Other,24332653.0,
779,1063187,3,1,,103542516,10133,Unspecified,,,130.1,IC50,Cytotoxicity against human HT1080 cells assessed as cell viability after 24 hrs by MTT assay,Confirmatory,24332653.0,
780,1063189,3,1,,103542516,10133,Unspecified,,,106.0,IC50,Cytotoxicity against human Caco2 cells assessed as cell viability after 24 hrs by MTT assay,Confirmatory,24332653.0,
781,1079931,1,1,,103542516,10133,Unspecified,,,,,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",Other,15646539.0,
782,1079932,1,1,,103542516,10133,Unspecified,,,,,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",Other,15646539.0,
783,1079933,1,1,,103542516,10133,Unspecified,,,,,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",Other,15646539.0,
784,1079934,1,1,,103542516,10133,Unspecified,,,,,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",Other,15646539.0,
785,1079935,1,1,,103542516,10133,Unspecified,,,,,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",Other,15646539.0,
786,1079936,1,1,,103542516,10133,Unspecified,,,,,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",Other,15646539.0,
787,1079937,1,1,,103542516,10133,Unspecified,,,,,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",Other,15646539.0,
788,1079938,1,1,,103542516,10133,Unspecified,,,,,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",Other,15646539.0,
789,1079939,1,1,,103542516,10133,Unspecified,,,,,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",Other,15646539.0,
790,1079940,1,1,,103542516,10133,Unspecified,,,,,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",Other,15646539.0,
791,1079941,1,1,,103542516,10133,Unspecified,,,,,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",Other,15646539.0,
792,1079942,1,1,,103542516,10133,Unspecified,,,,,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",Other,15646539.0,
793,1079943,1,1,,103542516,10133,Unspecified,,,,,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",Other,15646539.0,
794,1079944,1,1,,103542516,10133,Unspecified,,,,,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",Other,15646539.0,
795,1079945,1,1,,103542516,10133,Unspecified,,,,,Animal toxicity known. [column 'TOXIC' in source],Other,15646539.0,
796,1079946,1,1,,103542516,10133,Unspecified,,,,,Presence of at least one case with successful reintroduction. [column 'REINT' in source],Other,15646539.0,
797,1079947,1,1,,103542516,10133,Unspecified,,,,,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],Other,15646539.0,
798,1079948,1,1,,103542516,10133,Unspecified,,,,,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",Other,15646539.0,
799,1079949,1,1,,103542516,10133,Unspecified,,,,,Proposed mechanism(s) of liver damage. [column 'MEC' in source],Other,15646539.0,
800,1115404,1,4,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at Homo sapiens (human) FXR ligand binding domain expressed in HepG2 cells assessed as transactivation of SHP gene expression at 1 uM after 48 hr by luciferase reporter gene assay relative to control,Other,,
801,1115408,1,4,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at Homo sapiens (human) FXR ligand binding domain expressed in HepG2 cells assessed as transactivation of GAL4 gene expression at 10 uM after 48 hr by luciferase reporter gene assay relative to control,Other,,
802,1124818,1,3,,103542516,10133,Unspecified,46577705.0,9971.0,,,Activation of FXR (unknown origin) at 10 uM,Other,24630693.0,
803,1138165,1,2,,103542516,10133,Inactive,,,,,Induction of cAMP production in GP-BAR1-deficient HEK293T cells at 10 uM by cAMP responsive element containing luciferase reporter gene assay,Other,24387325.0,
804,1138170,1,3,,103542516,10133,Active,46577705.0,9971.0,,,Agonist activity at FXR in human HepG2 cells assessed as upregulation of SHP mRNA expression at 10 uM after 18 hrs by RT-PCR analysis,Other,24387325.0,
805,1138171,1,3,,103542516,10133,Active,46577705.0,9971.0,,,Agonist activity at FXR in human HepG2 cells assessed as upregulation of OST-alpha mRNA expression at 10 uM after 18 hrs by RT-PCR analysis,Other,24387325.0,
806,1138172,1,3,,103542516,10133,Active,46577705.0,9971.0,,,Agonist activity at FXR in human HepG2 cells assessed as upregulation of BESP mRNA expression at 10 uM after 18 hrs by RT-PCR analysis,Other,24387325.0,
807,1159509,1,1,,144207689,10133,Inconclusive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
808,1159515,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
809,1159516,1,1,,144207689,10133,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
810,1159517,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
811,1159518,1,1,,144207689,10133,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
812,1159519,1,1,,144207689,10133,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
813,1159520,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
814,1159521,1,1,,144207689,10133,Inactive,15928672.0,19885.0,61.3171,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
815,1159523,1,1,,144207689,10133,Inconclusive,15928672.0,19885.0,54.6489,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
816,1159524,1,1,,56463362,10133,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
817,1159525,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
818,1159526,1,1,,144207689,10133,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
819,1159527,1,1,,144207689,10133,Inconclusive,325495497.0,6256.0,19.5534,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
820,1159528,1,1,,144207689,10133,Inconclusive,119627033.0,3725.0,58.3745,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
821,1159529,1,1,,144207689,10133,Inconclusive,,,55.1091,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
822,1159531,1,1,,144207689,10133,Inconclusive,325495497.0,6256.0,19.5534,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
823,1159550,3,1,,252402756,10133,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
824,1159551,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
825,1159552,1,1,,144207689,10133,Inactive,325495463.0,5914.0,19.3902,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
826,1159553,2,1,,144207689,10133,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
827,1159555,1,1,,144207689,10133,Inconclusive,325495463.0,5914.0,19.3902,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
828,1159606,1,1,,56463362,10133,Inactive,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
829,1159607,2,1,,312596686,10133,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
830,1159620,1,1,,103542516,10133,Active,,,,,Summary of drug indications.,Other,,
831,1161666,1,2,,103542516,10133,Active,46577705.0,9971.0,,,Agonist activity at FXR (unknown origin) expressed in human HepG2 cells assessed as stimulation of FXR response element IR1-mediated receptor transactivation at 1 uM by luciferase reporter gene assay,Other,25162837.0,
832,1161667,1,2,,103542516,10133,Active,74762624.0,151306.0,,,Agonist activity at human GPBAR1 expressed in HEK293T cells assessed as stimulation of cAMP response element-mediated receptor transactivation at 10 uM by luciferase reporter gene assay,Other,25162837.0,
833,1161670,1,2,,103542516,10133,Inactive,46577705.0,9971.0,,,Antagonist activity against FXR (unknown origin) expressed in human HepG2 cells assessed as inhibition of CDCA-induced stimulation of FXR response element IR1-mediated receptor transactivation at 50 uM by luciferase reporter gene assay,Other,25162837.0,
834,1165586,1,2,,103542516,10133,Active,46577705.0,9971.0,,,Agonist activity at FXR (unknown origin) expressed in human HepG2 cells assessed as receptor transactivation at 10 uM incubated for 16 hrs by FXR response element driven HSP27-TK-luciferase reporter gene assay,Other,25247751.0,
835,1165599,1,2,,103542516,10133,Active,46577705.0,9971.0,,,Agonist activity at human FXR ligand binding domain assessed as induction of biotinylated SRC1 peptide recruitment at 4 uM by coactivator recruitment assay,Other,25247751.0,
836,1166181,1,2,,103542516,10133,Active,46577705.0,9971.0,18.0,EC50,Agonist activity at human FXR expressed in human HeLa cells assessed as receptor activation by BSEP promoter-driven firefly luciferase reporter gene assay,Confirmatory,25255039.0,
837,1166182,1,2,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human FXR expressed in human HeLa cells assessed as receptor activation by BSEP promoter-driven firefly luciferase reporter gene assay relative to 3 uM GW4064,Other,25255039.0,
838,1166186,1,2,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at FXR in human HepG2 cells assessed as induction of SHP mrNA expression at 50 uM by quantitative PCR method,Other,25255039.0,
839,1166192,1,2,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at FXR in human HepG2 cells assessed as induction of CYP7A1 mrNA expression at 50 uM by quantitative PCR method,Other,25255039.0,
840,1166198,1,2,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at FXR in human HepG2 cells assessed as induction of OSTalpha mrNA expression at 50 uM by quantitative PCR method,Other,25255039.0,
841,1166204,1,2,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at FXR in human HepG2 cells assessed as induction of BSEP mrNA expression at 50 uM by quantitative PCR method,Other,25255039.0,
842,1166210,1,2,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at FXR in human HepG2 cells assessed as induction of IBABP mrNA expression at 50 uM by quantitative PCR method,Other,25255039.0,
843,1187912,1,2,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at GAL4 DNA binding domain tagged FXR ligand binding domain (unknown origin) expressed in human HepG2 cells assessed as receptor transactivation measured by relative luciferase activity at 10 uM by luciferase reporter gene based mammalian one-hybrid assay relative to untreated control,Other,25127166.0,
844,1187915,1,2,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at GAL4 DNA binding domain tagged FXR ligand binding domain (unknown origin) expressed in human HepG2 cells co-expressing human human SHP gene promoter assessed as transactivation of SHP promoter driven luciferase activity at 10 uM relative to untreated control,Other,25127166.0,
845,1187920,1,2,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at GAL4 DNA binding domain tagged FXR ligand binding domain (unknown origin) expressed in human HepG2 cells co-expressing rat CYP7A1 gene promoter assessed as transrepression of CYP7A1 promoter driven luciferase activity at 10 uM,Other,25127166.0,
846,1187925,1,2,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at GAL4 DNA binding domain tagged FXR ligand binding domain (unknown origin) expressed in human HepG2 cells co-expressing human PLTP gene promoter assessed as transactivation of PLTP promoter driven luciferase activity at 10 uM relative to untreated control,Other,25127166.0,
847,1193333,1,2,,103542516,10133,Active,74762624.0,151306.0,6.1,EC50,Agonist activity at human GPBAR1 expressed in HEK293 cells assessed as increase in intracellular cAMP level after 30 mins by cAMP-Glo assay,Confirmatory,25735208.0,
848,1224834,3,1,,144207689,10133,Inconclusive,,,61.3171,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
849,1224835,1,1,,144207689,10133,Active,160794.0,,79.9007,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
850,1224836,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
851,1224837,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
852,1224838,1,1,,144207689,10133,Inactive,66775687.0,9970.0,54.6489,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
853,1224839,1,1,,144207689,10133,Inconclusive,66775687.0,9970.0,61.3171,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
854,1224840,3,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
855,1224841,3,1,,144207689,10133,Inactive,325495545.0,2101.0,61.3171,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
856,1224842,3,1,,144207689,10133,Inconclusive,325495545.0,2101.0,68.7989,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
857,1224843,1,1,,144207689,10133,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
858,1224844,1,1,,144207689,10133,Inconclusive,,,39.0142,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
859,1224845,1,1,,144207689,10133,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
860,1224846,1,1,,144207689,10133,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
861,1224847,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
862,1224848,3,1,,144207689,10133,Inactive,325495545.0,2101.0,27.3893,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
863,1224849,3,1,,144207689,10133,Inconclusive,325495545.0,2101.0,27.3893,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
864,1224863,1,1,,176484776,10133,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
865,1224865,1,2,,56463362,10133,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
866,1224867,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
867,1224868,1,1,,144207689,10133,Inconclusive,,,49.11600000000001,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
868,1224869,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
869,1224870,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
870,1224871,1,1,,144207689,10133,Inconclusive,,,4.3775,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
871,1224872,1,1,,144207689,10133,Inconclusive,,,49.11600000000001,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
872,1224873,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
873,1224874,1,1,,144207689,10133,Inconclusive,,,49.11600000000001,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
874,1224875,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
875,1224876,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
876,1224877,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
877,1224878,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
878,1224879,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
879,1224880,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
880,1224881,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
881,1224882,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
882,1224883,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
883,1224884,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
884,1224885,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
885,1224886,1,1,,144207689,10133,Inconclusive,,,49.11600000000001,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
886,1224887,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
887,1224888,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
888,1224889,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
889,1224890,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
890,1224892,1,1,,144207689,10133,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
891,1224893,1,1,,144207689,10133,Inconclusive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
892,1224894,1,1,,144207689,10133,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
893,1224895,1,1,,144207689,10133,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
894,1224896,1,1,,144207689,10133,Inconclusive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
895,1232938,1,1,,103542516,10133,Active,46577705.0,9971.0,18.0,EC50,Agonist activity at human full length FXR expressed in HeLa cells cotransfected with pSG5-human RXR after 24 hrs by Dual-Glo luciferase reporter gene assay,Confirmatory,25934227.0,
896,1232939,1,1,,103542516,10133,Unspecified,46577705.0,9971.0,,,Agonist activity at human full length FXR expressed in HeLa cells cotransfected with pSG5-human RXR after 24 hrs by Dual-Glo luciferase reporter gene assay relative to 3 uM GW4064,Other,25934227.0,
897,1232958,1,1,,103542516,10133,Unspecified,46577705.0,9971.0,,,Partial agonist activity at FXR in human HepG2 cells assessed as induction of BSEP gene expression at 50 uM after 24 hrs by qRT-PCR analysis (Rvb = 100%),Other,25934227.0,
898,1232961,1,1,,103542516,10133,Unspecified,46577705.0,9971.0,,,Partial agonist activity at FXR in human HepG2 cells assessed as induction of SHP gene expression at 50 uM after 24 hrs by qRT-PCR analysis (Rvb = 100%),Other,25934227.0,
899,1232963,1,1,,103542516,10133,Unspecified,46577705.0,9971.0,,,Partial agonist activity at FXR in human HepG2 cells assessed as induction of OST-alpha gene expression at 50 uM after 24 hrs by qRT-PCR analysis (Rvb = 100%),Other,25934227.0,
900,1232965,1,1,,103542516,10133,Unspecified,46577705.0,9971.0,,,Partial agonist activity at FXR in human HT-29 cells assessed as induction of IBABP gene expression at 50 uM after 24 hrs by qRT-PCR analysis (Rvb = 100%),Other,25934227.0,
901,1233552,1,1,,103542516,10133,Inconclusive,,,,IC50,Cytotoxicity against human WI38 cells by MTT assay,Confirmatory,26063305.0,
902,1233553,1,1,,103542516,10133,Inconclusive,,,,IC50,Antitrypanosomal activity against Trypanosoma brucei brucei Lister 427 bloodstream forms by microtiter plate based assay,Confirmatory,26063305.0,
903,1233559,1,1,,103542516,10133,Active,,,18.9,IC50,Antiplasmodial activity against Plasmodium falciparum 3D7 assessed as reduction in parasite viability by parasite lactate dehydrogenase assay,Confirmatory,26063305.0,
904,1233565,1,1,,103542516,10133,Unspecified,,,,,Cytotoxicity against human WI38 cells assessed as inhibition of cell growth at 100 ug/ml by MTT assay,Other,26063305.0,
905,1233566,1,1,,103542516,10133,Unspecified,,,,,Cytotoxicity against human WI38 cells assessed as inhibition of cell growth at 20 ug/ml by MTT assay,Other,26063305.0,
906,1233567,1,1,,103542516,10133,Unspecified,,,,,Antitrypanosomal activity against Trypanosoma brucei brucei Lister 427 bloodstream forms assessed as inhibition of parasite growth at 100 ug/ml by microtiter plate based assay,Other,26063305.0,
907,1233568,1,1,,103542516,10133,Unspecified,,,,,Antitrypanosomal activity against Trypanosoma brucei brucei Lister 427 bloodstream forms assessed as inhibition of parasite growth at 20 ug/ml by microtiter plate based assay,Other,26063305.0,
908,1233569,1,1,,103542516,10133,Unspecified,,,,,Antiplasmodial activity against Plasmodium falciparum 3D7 assessed as inhibition of parasite viability at 100 ug/ml by parasite lactate dehydrogenase assay,Other,26063305.0,
909,1233570,1,1,,103542516,10133,Unspecified,,,,,Antiplasmodial activity against Plasmodium falciparum 3D7 assessed as inhibition of parasite viability at 20 ug/ml by parasite lactate dehydrogenase assay,Other,26063305.0,
910,1234671,1,1,,103542516,10133,Unspecified,,,236.1,IC50,Antiparasitic activity against Trypanosoma cruzi strain CL Brener epimastigotes after 12 days by ELISA reader,Confirmatory,26072173.0,
911,1234672,1,1,,103542516,10133,Inactive,,,,,Antiparasitic activity against Trypanosoma cruzi strain CL Brener epimastigotes at 300 uM after 12 days by ELISA reader,Other,26072173.0,
912,1259241,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
913,1259242,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
914,1259243,1,1,,144207689,10133,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
915,1259244,1,1,,144207689,10133,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
916,1259247,1,1,,144207689,10133,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
917,1259248,1,1,,144207689,10133,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
918,1259313,1,1,,56463362,10133,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
919,1259318,1,1,,56463362,10133,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
920,1259344,1,1,,144203963,10133,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
921,1259355,1,1,,144203963,10133,Inconclusive,,,5.6234,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
922,1259356,1,1,,144203963,10133,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
923,1259364,1,1,,144207689,10133,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
924,1259365,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
925,1259366,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
926,1259367,1,1,,144207689,10133,Inconclusive,,,54.6489,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
927,1259368,1,1,,144207689,10133,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
928,1259369,1,1,,144207689,10133,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
929,1259377,1,1,,144207689,10133,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
930,1259378,1,1,,144207689,10133,Inconclusive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
931,1259379,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
932,1259380,1,1,,144207689,10133,Inconclusive,,,61.3171,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
933,1259381,1,1,,144207689,10133,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
934,1259382,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
935,1259383,1,1,,144207689,10133,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
936,1259384,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
937,1259385,1,1,,144207689,10133,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
938,1259386,1,1,,144207689,10133,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
939,1259387,1,1,,144207689,10133,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
940,1259388,1,1,,144207689,10133,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
941,1259390,1,1,,144207689,10133,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
942,1259391,1,1,,144207689,10133,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
943,1259392,1,1,,144207689,10133,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
944,1259393,1,1,,144207689,10133,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
945,1259394,1,1,,144207689,10133,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
946,1259395,1,1,,144207689,10133,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
947,1259396,1,1,,144207689,10133,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
948,1259401,1,1,,144207689,10133,Inconclusive,325495545.0,2101.0,64.9504,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
949,1259402,1,1,,144207689,10133,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
950,1259403,1,1,,144207689,10133,Inconclusive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
951,1259404,1,1,,144207689,10133,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
952,1259407,1,1,,363900145,10133,Inactive,,,,,CCRIS mutagenicity studies,Other,,
953,1259415,1,1,,56463362,10133,Inactive,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
954,1259416,1,2,,375192638,10133,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
955,1259421,1,1,,375192638,10133,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
956,1259423,1,2,,354797348,10133,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
